Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2022 | Story Andre Damons | Photo Reuben Maeko
Dr Nicholas Pearce, Head of the Department of General Surgery in the Faculty of Health Sciences at the University of the Free State (UFS), shows off his new socks with some of the students who came out to celebrate the day.

The high-pressure nature of working in the health sector and some of the conditions under which doctors have to work and to which they are exposed not only make them vulnerable, but it might have an effect on their mental state. 

It is for this reason that the Faculty of Health Sciences at the University of the Free State (UFS) celebrates the
CrazySocks4Docs campaign each year. In order to create awareness on the importance of medical students’ mental health, Investec once again sponsored crazy socks for our undergraduate medical students this year, after a very successful CrazySocks4Docs Day in 2021. 

Crazy Socks for Docs was created in 2017 by Victorian doctor Geoff Toogood, who has a lived experience of depression and anxiety. 

After wearing odd socks to work one day, Dr Toogood found that people were talking behind his back and questioning his mental health. The reality was that his new puppy ate his socks, but he was struck by the stigma and discrimination still associated with mental health and well-being.

Angie Vorster, Clinical Psychologist from the School of Medicine in the Faculty of Health Sciences, says students and staff were encouraged to wear mismatched, colourful, crazy socks on 3 June 2022 in order to draw attention to the mental health and well-being of our medical students and medical doctors – who have carried us through more than two years of a pandemic. 

“The more we speak about mental health and change the narrative around mental illness as normal life experiences, the better we are able to reduce stigma and increase help-seeking behaviour among our healthcare professionals,” says Vorster.

Head of Surgery, Dr Nicholas Pearce; Acting Head of the School of Clinical Medicine, Prof Hanneke Brits; the Programme Director of the Undergraduate School of Clinical Medicine, Dr Yolandi Swart; and Arishka Kalicharan, the Phase I Chairperson, along with the School of Clinical Medicine's Clinical Psychologist, Angie Vorster, came to celebrate their socks with medical students. 

“The students took a break from studying for their exams to have some fun. Even though it was freezing outside, our toes were as warm as our hearts. A great big word of thanks to Investec for caring about our students' mental health and always supporting our endeavours in the Faculty of Health Sciences. It takes a village to train a doctor!’

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept